Education

Ph.D. in Molecular pharmacology, Pierre Fabre Laboratories (Pharmaceutical Industry) and University of Toulouse, France, 2002

Pharm. D., Faculty of Pharmacy, Lyon, France, 2000

Current position

Associate Professor in Toxicology in Pharmacy, Faculty of Pharmacy, University of Toulouse, France

Publications (since 2005)

1. Fedor, Y., Vignard, J., Nicolau-Travers, M. L., Boutet-Robinet, E., Watrin, C., Salles, B. and Mirey, G. (2013). From single-strand breaks to double-strand breaks during S-phase: a new mode of action of the Escherichia coli Cytolethal Distending Toxin. Cell Microbiol 15(1): 1-15.
   
2. Courilleau, C., Chailleux, C., Jauneau, A., Grimal, F., Briois, S., Boutet-Robinet, E., Boudsocq, F., Trouche, D. and Canitrot, Y. (2012). The chromatin remodeler p400 ATPase facilitates Rad51-mediated repair of DNA double-strand breaks. J Cell Biol 199(7): 1067-1081.
   
3. Najib, S., Saint-Laurent, N., Esteve, J. P., Schulz, S., Boutet-Robinet, E., Fourmy, D., Lattig, J., Mollereau, C., Pyronnet, S., Susini, C. and Bousquet, C. (2012). A switch of G protein-coupled receptor binding preference from phosphoinositide 3-kinase (PI3K)-p85 to filamin A negatively controls the PI3K pathway. Mol Cell Biol 32(5): 1004-1016.
   
4. Herin, F., Boutet-Robinet, E., Levant, A., Dulaurent, S., Manika, M., Galatry-Bouju, F., Caron, P. and Soulat, J. M. (2011). Thyroid function tests in persons with occupational exposure to fipronil. Thyroid 21(7): 701-706.
   
5. Cussac, D., Boutet-Robinet, E., Ailhaud, M. C., Newman-Tancredi, A., Martel, J. C., Danty, N. and Rauly-Lestienne, I. (2008). Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells. Eur J Pharmacol 594(1-3): 32-38.
   
6. Rauly-Lestienne, I., Boutet-Robinet, E., Ailhaud, M. C., Newman-Tancredi, A. and Cussac, D. (2007). Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. Naunyn Schmiedebergs Arch Pharmacol 376(1-2): 93-105.